Comparative assessment of the quadriceps and the diaphragm in patients with COPD.

Chronic obstructive pulmonary disease (COPD) and other chronic diseases such as heart failure are accompanied by skeletal muscle alterations that further enhance morbidity and mortality in affected individuals. Several studies have highlighted important structural and biochemical modifications in limb and respiratory muscles in COPD. Reviewing the similarities and differences between the two most studied muscles in COPD, the quadriceps and the diaphragm, may be helpful in providing important clues about the mechanisms underlying muscle changes associated with this disease. Although oxidative stress is present in both muscles, other muscle alterations are clearly distinct between the quadriceps and the diaphragm. For example, the oxidative metabolism varies in opposite directions, the diaphragm exhibiting increased resistance to fatigue while the quadriceps in COPD is characterized by premature fatigability. Differences in muscle phenotypic expression between the diaphragm and the quadriceps indicate that, in addition to systemic factors, the local microenvironment must participate in the reorganization seen in these two skeletal muscles in COPD.

[1]  T. Clanton,et al.  Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation? , 2009, Journal of applied physiology.

[2]  S. Hussain,et al.  Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients , 2009, European Respiratory Journal.

[3]  A. Agustí,et al.  Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients , 2009, European Respiratory Journal.

[4]  N. Hopkinson,et al.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. , 2009, American journal of respiratory and critical care medicine.

[5]  J. Bourbeau,et al.  The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction? , 2008, American journal of respiratory and critical care medicine.

[6]  J. Barberà,et al.  Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD , 2008, Thorax.

[7]  L. Grimelius,et al.  Overexpression of von Hippel-Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease , 2008, Journal of Clinical Pathology.

[8]  K. Webb,et al.  Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  T. Duhamel,et al.  Abnormal sarcoplasmic reticulum Ca2+-sequestering properties in skeletal muscle in chronic obstructive pulmonary disease. , 2008, American journal of physiology. Cell physiology.

[10]  D. Gerrard,et al.  Modulation of skeletal muscle fiber type by mitogen‐activated protein kinase signaling , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Amy E. Knapp,et al.  Skeletal muscle capillarity during hypoxia: VEGF and its activation. , 2008, High altitude medicine & biology.

[12]  Marco Sandri,et al.  Signaling in muscle atrophy and hypertrophy. , 2008, Physiology.

[13]  M. Polkey,et al.  Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease , 2008, The Journal of physiology.

[14]  E. Barreiro,et al.  Activación de células satélite en el músculo intercostal de pacientes con EPOC , 2008 .

[15]  A. Brunet,et al.  The FoxO code , 2008, Oncogene.

[16]  P. Wagner,et al.  Possible mechanisms underlying the development of cachexia in COPD , 2008, European Respiratory Journal.

[17]  Jeong-Ho Kim,et al.  Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components. , 2008, Endocrinology.

[18]  C. Ottenheijm,et al.  Diaphragm adaptations in patients with COPD , 2008, Respiratory research.

[19]  F. Maltais,et al.  Profiling of mRNA Expression in Quadriceps of Patients with COPD and Muscle Wasting , 2008, COPD.

[20]  M. Polkey,et al.  Cytokine profile in quadriceps muscles of patients with severe COPD , 2007, Thorax.

[21]  A. Russell,et al.  Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[22]  P. Schrauwen,et al.  Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD , 2007, European Respiratory Journal.

[23]  M. Hesselink,et al.  Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD , 2007, European Respiratory Journal.

[24]  C. Ottenheijm,et al.  Diaphragm muscle fiber dysfunction in chronic obstructive pulmonary disease: toward a pathophysiological concept. , 2007, American journal of respiratory and critical care medicine.

[25]  S. Zakynthinos,et al.  Effects of rehabilitative exercise on peripheral muscle TNF&agr;, IL-6, IGF-I and MyoD expression in patients with COPD , 2007, Thorax.

[26]  Maurice P Zeegers,et al.  Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis , 2007, Thorax.

[27]  Bingwen Jin,et al.  Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[28]  R. Rodenburg,et al.  Metabolic capacity of the diaphragm in patients with COPD. , 2006, Respiratory medicine.

[29]  J. Viña,et al.  Oxidative and nitrosative stress in the diaphragm of patients with COPD , 2006, International journal of chronic obstructive pulmonary disease.

[30]  E. Wouters,et al.  COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. , 2006, Primary care respiratory journal : journal of the General Practice Airways Group.

[31]  C. Ottenheijm,et al.  Titin and diaphragm dysfunction in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[32]  W. Reid,et al.  Increased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations , 2006, European Respiratory Journal.

[33]  C. Ottenheijm,et al.  Diaphragm dysfunction in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[34]  E. Wouters,et al.  Body composition and mortality in chronic obstructive pulmonary disease. , 2005, The American journal of clinical nutrition.

[35]  S. Hussain,et al.  Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[36]  F. Maltais,et al.  Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD , 2004, European Respiratory Journal.

[37]  R. Casaburi,et al.  Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[38]  Hiroyuki Aburatani,et al.  Skeletal Muscle FOXO1 (FKHR) Transgenic Mice Have Less Skeletal Muscle Mass, Down-regulated Type I (Slow Twitch/Red Muscle) Fiber Genes, and Impaired Glycemic Control*[boxs] , 2004, Journal of Biological Chemistry.

[39]  Naftali Kaminski,et al.  Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. , 2004, Journal of applied physiology.

[40]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[41]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[42]  A. Goldberg,et al.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  M. Orozco-Levi Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? , 2003, European Respiratory Journal.

[44]  M. Decramer,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003 .

[45]  E. Wouters,et al.  Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[46]  P. Hasselgren,et al.  Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. , 2003, The international journal of biochemistry & cell biology.

[47]  X. Bigard,et al.  Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[48]  F. Maltais,et al.  In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD , 2003, European Respiratory Journal.

[49]  J. Gea,et al.  COPD and body weight in a Mediterranean population. , 2002, Clinical nutrition.

[50]  Y. Lacasse,et al.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[51]  G. Kwakkel,et al.  Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis , 2002, European Respiratory Journal.

[52]  X. Busquets,et al.  Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[53]  Jiandie D. Lin,et al.  Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres , 2002, Nature.

[54]  Maria Cristina C Gomes-Marcondes,et al.  Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. , 2002, Cancer letters.

[55]  H. van Mameren,et al.  Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[56]  C. Gregory,et al.  Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. , 2002, Journal of applied physiology.

[57]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Gea,et al.  Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[59]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[60]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[61]  J. Barberà,et al.  Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[62]  E. Bozkanat,et al.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease , 2001, Respiratory research.

[63]  J. Gea,et al.  Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. , 2001, The European respiratory journal.

[64]  F. Maltais,et al.  Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD , 2000, Thorax.

[65]  A. Goris,et al.  Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[66]  M. Decramer,et al.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. , 2000, The American journal of clinical nutrition.

[67]  J. Shrager,et al.  Developmental myosin heavy chains in the adult human diaphragm: coexpression patterns and effect of COPD. , 2000, Journal of applied physiology.

[68]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[69]  J. Gea,et al.  Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[70]  F. Maltais,et al.  Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. , 1998, Journal of cardiopulmonary rehabilitation.

[71]  L. Kaiser,et al.  Cellular Adaptations in the Diaphragm in Chronic Obstructive Pulmonary Disease , 1998 .

[72]  F. Maltais,et al.  Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. , 1998, Medicine and science in sports and exercise.

[73]  W. Zhu,et al.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. , 1998, Genes & development.

[74]  F. Maltais,et al.  Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[75]  I. Harting,et al.  Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[76]  M. Tisdale Biology of cachexia. , 1997, Journal of the National Cancer Institute.

[77]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[78]  M. Buck,et al.  Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. , 1996, The EMBO journal.

[79]  P. Macklem,et al.  Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[80]  N. Jones,et al.  Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. , 1995, American journal of respiratory and critical care medicine.

[81]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[82]  P. Macklem,et al.  Contractile properties of the human diaphragm during chronic hyperinflation. , 1991, The New England journal of medicine.

[83]  A. Grassino,et al.  Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[84]  D. F. Rochester,et al.  COPD and human diaphragm muscle dimensions. , 1987, Chest.

[85]  H. Hoppeler,et al.  Influences of endurance training on the ultrastructural composition of the different muscle fiber types in humans , 1985, Pflügers Archiv.

[86]  C. Roussos,et al.  Diaphragm in emphysematous hamsters: sarcomere adaptability. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[87]  L. Larsson Histochemical characteristics of human skeletal muscle during aging. , 1983, Acta physiologica Scandinavica.

[88]  L. Heunks,et al.  Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.

[89]  E. Barreiro,et al.  [Activation of satellite cells in the intercostal muscles of patients with chronic obstructive pulmonary disease]. , 2008, Archivos de bronconeumologia.

[90]  B. Nordestgaard,et al.  Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. , 2006, American journal of respiratory and critical care medicine.

[91]  A. McArdle,et al.  Skeletal Muscle Damage with Exercise and Aging , 2005, Sports medicine.

[92]  W. Mitch,et al.  Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. , 2004, The Journal of clinical investigation.

[93]  Marc S. Williams Myostatin mutation associated with gross muscle hypertrophy in a child. , 2004, The New England journal of medicine.

[94]  Jiandie D. Lin,et al.  Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. , 2002, Nature.

[95]  A. Goldberg,et al.  Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.

[96]  F. Maltais,et al.  Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. , 1996, American journal of respiratory and critical care medicine.

[97]  B. Burrows The bronchial and emphysematous types of chronic obstructive lung disease in London and Chicago. , 1968, Aspen Emphysema Conference.